INYX REPORTS SHARP INCREASE IN SECOND-QUARTER RESULTS

Inyx, Inc. (OTC Bulletin Board: IYXI), a specialty pharmaceutical company focused on aerosol drug delivery technologies and products, reported today operating results for the second quarter and first half ended June 30, 2005. The company also reaffirmed its guidance for 2005. For the 2005 second quarter, revenues reached $8.5 million, the highest quarterly level in the company's history and more than triple the $2.8 million reported a year ago. There was a net loss in the 2005 quarter of $4.1 million, equal to $0.10 per share, compared with a net loss of $3.4 million, or $0.12 a share, in the year-earlier period.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-19-2005/0004091209&EDATE=)